November 3, 2011
Durham, NC
SEBIO
Wyrick Robbins
Finnegan, Wyrick Robbins, and SEBIO invite you to attend a complimentary workshop directed to business executives and corporate attorneys of emerging biotechnology, pharmaceutical, and medical device companies.
Presentations will provide practical guidance on:
• Strategies for Developing a Valuable IP Portfolio,
Presented by Finnegan
Learn how to develop a comprehensive IP management strategy
that protects your company’s core technologies while also
advancing business goals and optimizing value for financing,
licensing negotiations, or acquisition.
• Analyzing the Series A Term Sheet,
Presented by Wyrick Robbins
A comprehensive overview of the principles involved in negotiation
of investor documentation, including an analysis and illustration of
the inner workings of convertible securities, anti-dilution protection,
protective covenants, and corporate governance typically included
in a Series A Term Sheet.
Please join us to learn the essentials for developing and maintaining a valuable IP portfolio and financing an emerging technology company.
The complimentary two-hour seminar will be held immediately following the 2011 SEBIO Investor Forum awards ceremony.
Larry E. Robbins
2:30 - 4:30 p.m.
SEBIO Investor Forum 2011
Washington Duke Inn & Golf Club
Durham, NC 27705
Please click here to register by October 28, 2011.
June 10-12, 2024
San Francisco
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.